New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
07:05 EDTCPIXCumberland licenses Caldolor injection to Sandor for India commercialization
Cumberland announced that it has entered into an exclusive agreement with Sandor Medicaids Pvt. Ltd., an India-based pharmaceutical company, for the commercialization of Caldolor Injection in India. Under the terms of the agreement, Sandor Medicaids Pvt. Ltd. is responsible for seeking regulatory approval for Caldolor and, following approval, would handle ongoing distribution and sales in the territory. Cumberland maintains responsibility for product formulation, development and manufacturing, and will provide finished product for sale. In exchange for the license to the product, Cumberland will receive upfront and milestone payments, a transfer price and royalties on future sales of Caldolor.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2016
08:05 EDTCPIXCumberland and Piramal launch co-promotion of Caldolor and Vaprisol
Piramal Critical Care, an integral business unit of Piramal Enterprises and Cumberland Pharmaceuticals announced that they have officially launched co-promotion of two of Cumberland's branded hospital products, Caldolor and Vaprisol throughout the U.S. Caldolor, ibuprofen, Injection is the first injectable product approved in this country for the treatment of pain and fever in adults. The brand recently received FDA approval for the management of pain and reduction of fever use in pediatric patients six months and older. Vaprisol is the only injectable brand available to treat hyponatremia, the most common electrolyte imbalance in U.S. hospitalized patients.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use